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Introduction
For long, plants have been utilized by man in treatment 
of various ailments and diseases. Medicinal plants are 
important source of pharmacological and toxicological 
value. Furthermore, an increasing reliance on the use of 
medicinal plants in the industrialized societies has been 
traced to the extraction and development of several drugs 
and chemotherapeutics from these plants as well as from 
traditionally used rural herbal remedies (1). Biter leaf 
(Vernonia amygdalina) is an indigenous African plant 
species, which grows in most parts of sub-Saharan Africa. 
Vernonia is a genus of about 1000 species of forbs and 
shrubs of which V. amygdalina is the most prominent 
specie and one of the pantropical tribes of the family 
Asteraceae (2). It grows predominantly in tropical areas 
of Africa, especially in Nigeria, Zimbabwe and South 
Africa and it is domesticated in parts of West Africa (3). 
Traditional medicinal plants play an important role in 
the medical system in Nigeria; however, plant materials 
remain an important resource to combat serious diseases 
in the world. It has been reported that V. amygdalina 
has many medicinal properties such as antihelminth 
and laxative properties and possess cytotoxic effects 
towards human carcinoma cells, it is effective against 
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Implication for health policy/practice/research/medical education:
The ethanolic extract from V. amygdalina has phytochemicals such as flavonoids, tannins, alkaloids and steroids and the extract 
is non-toxic. It has pharmacological properties such as analgesic and antipyretic activities which could be due to the presence of 
secondary metabolites. 
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Introduction: Vernonia amygdalina Del. has been traditionally used in relieving pain and 
inflammatory conditions as well as in treatment of feverish conditions by local people of the North-
east Nigeria. Consequently this study aims at evaluating the phytochemical content, antipyretic 
and analgesic properties of V. amygdalina (biter leaf). 
Methods: The leaf of V. amygdalina was soxhlet extracted with ethanol and sequentially partitioned 
using solvent of different polarities. Phytochemical test was conducted to ascertain the secondary 
metabolites present in the extract using standard procedures. Acute toxicity (LD50) of the extract 
on laboratory rats was estimated by following protocols of Lorke. The antinociceptive activity of 
the ethanolic extract was also evaluated using acetic acid induced pain and hot plate method. 
Results: The results revealed the presence of tannins, phlobatannins, saponins, carbohydrates, 
cardioactive glycoside, flavonoids, alkaloids, steroids and terpenes. Anthraquinones were absent 
in the extract. The intraperitoneal LD50 was found to be 3721 mg/kg. On administration of 5000 
mg/kg dose of the extract via oral route, there was no dead. The extract demonstrated significant 
antinociceptive activities as 36.0 ± 0.81, 43.8 ± 0.11 and 52.8±0.37 (Mean number of writhings) 
respectively for the doses 600, 400 and 200 mg/kg i.p.) as compared to the control (60.0 ± 0.11). 
High dose of 400 mg/kg significantly reduced rectal temperature (P < 0.05)
Conclusion: These results demonstrated the medicinal potentiality of V. amygdalina and might 
be used as analgesic, and antipyretic agent. Phytochemicals found in such as flavonoids, tannins, 
alkaloids and steroids seem to be implicated in having such pharmacological activities.
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gastrointestinal disorders and has antimicrobial and 
antiparasitic activities. 
Vernonia amygdalina has been reported to be effective 
against amoebic dysentery, gastrointestinal disorders, 
hepatotoxicities and diabetes mellitus (4). The reported 
bioactive compounds of V. amygdalina are saponins, 
alkaloids, terpenes, steroids, coumarins, flavonoids, 
phenolic acids, lignans, xanthones, anthraquinones (5), 
edotides (4), tannins (6) and sesquiterpene lactone (7). 
These compounds have been shown to be responsible 
for the observed biological activities. For example, the 
antiplasmodial (antimalarial) activity of its extracts has 
been related to the presence of flavonoids, saponins and 
alkaloids (7). 
Also, there has been report that V. amygdalina was used 
in relieving pain and inflammatory conditions as well as 
in treatment of feverish conditions by the local people, 
Numan in Adamawa state and Bali in Taraba state of the 
North-east Nigeria. Consequently, scientific basis for 
the folkloric claimed is needed to be established. So the 
aim of this research was to verify some pharmacological 
properties of V. amygdalina (obtained from Adamawa state 
of Nigeria), such as analgesic and antipyretic activities as 
well evaluating its phytochemical composition.
Materials and Methods
Sample collection and identification 
The leaves of V. amygdalina (biter leaf) was collected in 
Numan Local Government Area of Borno state of Nigeria. 
The plant specimen was identified and authenticated by 
a Plant Taxonomist, Prof. S. S. Sanusi of the Department 
of Biological Sciences, Faculty of Science, University of 
Maiduguri. The herbarium specimen with a voucher 
number 666b was deposited at the Post Graduate Research 
Laboratory, Department of Chemistry, University of 
Maiduguri, Nigeria. The leaf of V. amygdalina (biter leaf) 
was cleaned and air-dried in the laboratory. 800 g of the 
sample was pulverized into a coarse powder using mortar 
and pestle.
Extraction and phytochemical analysis
The weighed powdered air-dried sample (800 g) was 
soxhlet extracted with ethanol and partitioned sequentially 
with chloroform, ethyl acetate, and n-butanol. The extract 
obtained was concentrated to dryness in vacuo at 40°C 
using a rotary evaporator. The extract concentrate was 
labeled and the percentage yields were calculated in w/w. 
The ethanolic extract was subjected to qualitative chemical 
screening for identification of phytochemicals such 
as flavonoids, alkaloids, sterols, triterpenes, saponins, 
anthracenosides, tannins, polyuronides, emodol, etc as 
described by previous studies (8-10). 
Pharmacological evaluations
Animals
Eighty Albino rats of both sexes weighing 100-150 
g, thirty mice of both sexes weighing 20-30 g, and 2 
male rabbits were used for the experiments. They were 
obtained from a colony of rats maintained at the animal 
house of the Institute of Trypanosomiasis Research Vom, 
Nigeria. They were housed in clean cages and had access 
to feeds (ECWA Feeds) and water ad libitum. They were 
allowed to acclimatize for 2 weeks in the Veterinary 
Physiology, Pharmacology and Biochemistry Laboratory 
before the commencement of the study. All the animals 
were handled according to the guiding principles of 
biomedical research involving animals (11) as certified 
(VPPB, 069) by the ethics committee of Faculty of 
Veterinary Medicine, University of Maiduguri.
Acute toxicity evaluation (LD50)
The acute toxicity (LD50) value of the crude ethanolic leaf 
extract was determined using standard procedures (12). 
In this study two different routes of administration were 
considered, that were oral and intra-peritoneal. In phase 
I the rats were divided into 3 groups of three rats for each 
route and then treated with crude ethanolic extract at doses 
of 10, 100 and 1000 mg/kg body weight intraperitoneally 
and orally and observed for 24 hours for mortality. In the 
phase II, 4 rats for each route were divided into 4 groups 
of one rat each and the ethanolic extract was administered 
at various doses to be determined after the phase one. The 
final LD50 value was calculated as the geometric mean of 
the surviving group and the death group in the second 
phase. 
Effect of extract on acetic acid-induced writhing in Mice
Adult mice weighing 20-30 g were used for the experiment. 
The abdominal constriction resulting from i.p. injection 
of acetic acid (0.6% v/v) consisting of a contraction of 
abdominal muscle, together with a stretching of hind 
limbs, was carried out according to the procedure 
previously described (13-16). The animals were divided 
into 4 groups of 6 mice per cage. Group was served as 
control while the groups 2-4 were pretreated with graded 
doses (mg/kg) of the extract (i.p.). Thirty minutes later, 
acetic acid was administered. The number of writhing 
movements was counted for 30 minutes. 
Effect of extract on thermally-induced pain in mice
The effect of the extract on hot plate-induced test was 
investigated in mice (20-30 g). In this experiment, the 
electric hot plate was maintained at 45±1°C (as it was 
connected to the thermostatically controlled water bath). 
Animals were placed into a glass beaker of 50 cm3 diameter 
on the heated surface and the time(s) between placement 
and the shaking or licking of the paws or jumping was 
recorded as the index of response latency. An automatic 
30 seconds cut-off was used to prevent tissue damage. The 
animals were divided into 4 groups of 5 mice per cage. 
Group I was served as control and received only water. 
Groups 2-4 were pretreated with graded doses (g/kg) (i.p.) 
of the extract. Ten minutes prior to their being placed on 
the hot plate (13,14)
Antipyretic evaluation
The procedure described by Besra et al (17) was 
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adopted. Thirty-five rats of both sexes were used for 
this experiment. The rats were given a solution of 20% 
Brewer’s yeast (1 mL) subcutaneously at the neck region 
and fasted to induce fever. About 18 hours thereafter, their 
body weight and temperature were recorded. Twenty rats 
with elevated temperature were selected and divided into 
4 groups of 5 rats each. Group A served as the control 
and was given distilled water only; while groups B, C 
and D were given various doses of 100 mg/kg, 200 mg/
kg and 300 mg/kg of the methanolic extract. The body 
temperature of the rats in various groups was determined 
at 1 hour interval following the administration of the 
ethanolic extract using a probe thermometer.
Statistical analysis
Data were expressed as mean ± SD and mean ± SEM. Test 
of significance between control and treatment means 
was carried out by analysis of variance (ANOVA) using 
GraphPad software.
Results 
The extracts concentrate yield of ethanol was 17% w/w. 
Phytochemical analysis of the ethanolic leaves extract of 
V. amygdalina (biter leaf) revealed the presence of tannins, 
phlobatannins, saponins, carbohydrates, cardioactive 
glycoside, flavonoids, alkaloids, steroids and terpenes. 
Anthraquinones were absent in the extract (Table 1). 
Acute toxicity
The intraperitoneal LD50 was found to be 3721 mg/kg. On 
administration of 5000 mg/kg dose of the extract via oral 
route, there was no dead, hence the extract was considered 
safe to be administered.
Analgesic evaluations
All the doses were found to show significant (P < 0.05) 
analgesic activities (Table 2). The ethanolic extract 
demonstrated significant antinociceptive activities as 
36.0 ± 0.81, 43.8 ± 0.11 and 52.8 ± 0.37°C (Mean number 
of writhings) respectively for the doses of 600, 400 and 
200 mg/kg i.p. as compared to the control (60.0 ± 0.12) 
(P < 0.05). The activity was more pronounced at a high 
dose of 600 mg/kg which give the highness percentage of 
43.2% inhibition of the abdominal constriction induced 
by acetic. Also, the extract appeared to induce an increase 
in pain threshold to Eddy’s hot plate when compared to 
control (Table 3) (P < 0.05). 
Antipyretic evaluations
The ethanolic leaf extract of V. amygdalina possessed 
antipyretic properties (Table 4). High dose of 400 
mg/kg significantly reduced rectal temperature from 
40.22 ± 0.03°C after 18 hours of induction of fever by yeast 
to 38.10 ± 0.12°C after one hour on administration of the 
extract. Four hours later the rectal temperature reduced 
to 37.21 ± 0.23°C. Also aspirin (60 mg/kg) reduced the 
rectal temperature from 40.80 ± 0.13 on 18 hours of 
fever induction to 38.09 ± 0.10°C after just one hour and 
subsequently to 37.20 ± 0.21 after 5 hours. The effects 
of the aspirin (60 mg/kg) was high as compared to the 
extract.
Discussion
The presence of the phytochemicals or phytonutrients or 
secondary metabolites such as tannins, phlobatannins, 
saponins, carbohydrates, cardioactive glycoside, 
Table 1. Phytochemical analysis of ethanolic leaf extract of Vernonia 
amygdalina 
Class of chemical components Results
Test of Alkaloids
Dragendorff reagent +
Mayer’s reagent +
Test for flavonoid
Shinoda test +
Lead acetate test +
Sodium hydroxide test +
Ferric chlorides test +
Test for carbohydrate
General Test (Molish test) +
Test of monosaccharide –
Test for reducing sugar (Fehling test) +
Combine reducing sugar test +
Test for ketoses +
Test for pentose –
Test for tannins
Ferric chloride +
Lead acetate +
Hydrochloric acid test +
Test for free Anthraquinones (Bontrase) –
Test for combined anthraquinone –
Test for cardio active glycoside
Salkowski test +
Liebermann Burchard test +
Terpenoid test +
Test for soluble starch +
Test for phlobatannins +
Test for saponins
Frothing test +
Fehling test +
–  Absen; + Present in low concentration.
Table 2. Effects of stem bark ethanolic extract of Vernonia amygdalina 
of acetic acid (0.6 %) induced writhes in mice
Treatment Dose (mg/kg) No. of Writhes Mean ± SEM Protection (%)
Control (DW) 52.8 ± 0.37 0.00
Extract + AA 200 55.8 ± 0.37* 15.0
Extract + AA 400 43.8 ± 0.11* 30.1
Extract + AA 600 36.0 ±0.81* 40.9
Pentazocine + AA 60 4.60 ± 0.40* 93.0
Abbreviations: DW, distilled water; AA, acetic acid.
*P < 0.05 is significantly different from the control.
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flavonoids, alkaloids, steroids and terpenes could be 
the reason why V. amygdalina leaf has pharmacological 
activities. These chemical agents have been implicated 
in so many literatures of having medicinal relevance and 
properties such and reducing or relieving fever or pyrexia, 
blocking inflammatory acting on pain or analgesia, 
having antioxidant properties, antimicrobial activities, 
etc (13). As shown in Table 1, V. amygdalina has all the 
phytochemicals that have such activities listed and this 
might be the reason why it is used in local pharmacopoeia.
According the classification of Clarke and Clarke (18), 
substances that have an intraperitoneal LD50 between 50 
and 500 mg/kg are considered toxic. The fact that no dead 
was obtained with high doses tested and hence we could 
not get LD50, is might be indicated that the extract could 
be administered with some degree of safety both on the 
oral and intraperitoneal routes. 
The ethanolic extract demonstrated significant 
antinociceptive activities as 36.0 ± 0.81, 43.8 ± 0.11 and 
52.8±0.37 (Mean number of writhings), respectively 
for the doses 600, 400 and 200 mg/kg i.p. as compared 
to the control (60.0 ± 0.12). The activity was more 
pronounced at a high dose of 600 mg/kg which give the 
highness percentage of 43.2% inhibition of the abdominal 
constriction induced by acetic acid. This was found to be 
significantly lower than pentazocine (20 mg/kg) in the 
extent to which the writhing or stretching induced by 
acetic acid was reduced. 
All the doses were found to show significant (P < 0.05) 
Table 3. Effects of ethanolic extract of Vernonia amygdalina of thermal 
nociception in mice
Treatment Dose (mg/kg)
Time of pad licking 
or jumping (s)
No. of rats 
used
Control (DW) 1.90 ± 0.09 5
Extract 100 4.40 ± 0.55* 5
Extract 200 6.80 ± 0.44* 5
Extract 400 8.60 ± 0.55** 5
Pentazocine 20 10.0 ±0.54** 5
Abbreviation: DW, distilled water.
*P < 0.05 is significantly different from the control.
**P < 0.001 is significantly different from the control.
Table 4. Effect of ethanolic extract of Vernonia amygdalina against Brewer’s yeast induced hyperpyrexia in rats
Treatment groups 
(mg/kg)
Rectal temperature (man ±SD)
After yeast injection After drugs administration
i.p. 0 (min) 60 (min) 120 (min) 180 (min) 240 (min)
Control (DW) 37.0 39.3 ± 0.11 39.4 ± 0.12 38.1 ± 0.44 38.00 ± 0.22 37.9 ± 0.01
100 37.1 40.81 ± 0.34 40.11 ± 0.42 39.72 ± 0.12 38.90 ± 0.11 37.7 ± 0.24*
200 37.5 40.47 ± 0.55 39.12 ± 0.19* 38.80 ± 0.13 37.92 ± 0.12 37.50 ± 0.15*
300 37.5 39.91 ± 0.23 38.56 ± 0.17* 37.11 ± 0.24 * 37.14 ± 21* 37.0 2 ± 0.10*
400 37.5 40.22 ± 0.03 38.10 ± 0.13 38.00 ± 0.80* 37.9 ± 0.23 * 37.2 ± 0.23*
Aspirin (60 mg/kg) 37.5 40.80 ± 0.13 38.09 ± 0.10* 37.82 ± 0.14* 37.52 ± 0.67* 37.21 ± 0.23* 
*P < 0.05 significant compared to control.
analgesic activity. The analgesic activity may be due to 
presence of bioactive compounds such as flavonoids and 
tannins that are present in the extract. Flavonoids and 
tannins possessed analgesic and/or anti-inflammatory 
activities (19). Also, the extract appeared to induce an 
increase in pain threshold to Eddy’s hot plate when 
compared to control group. The various extract doses 
(200, 400 and 600 mg/kg) significantly increased the time 
of pad licking. Also pentazocine significantly increased 
the time of pad licking with superior effect compared to 
the extract.
The ethanolic leaf extract of V. amygdalina possessed 
antipyretic properties. Also aspirin (60 mg/kg) reduced 
the rectal temperature. Also, the extract efficacy in rectal 
temperature reduction was higher than the control. This 
observation supports the claim of local people in folkloric 
treatment of fever. Fever may be a result of infection or 
one of the consequence of tissue damage or other diseases 
state (16). Reduction of elevated body temperature may be 
due to presence of flavonoid compounds in the extract as 
some flavonoidal compounds are predominant inhibitors 
of cyclooxygenase and lipoxygenase (10).
Conclusion
Extraction of V. amygdalina yielded 17% w/w which is 
relatively high. Phytochemical analysis of the ethanolic 
leaf extract of revealed the presence of tannins, 
phlobatannins, saponins, carbohydrates, cardioactive 
glycoside, flavonoids, alkaloids, steroids and terpenes. 
The LD50 showed that the extract could be administered 
with some degree of safety. The extract has analgesic and 
antipyretic activities when tested on laboratory animals. 
These pharmacological properties observed could be due 
the presence of the secondary metabolites present in the 
extract and thus V. amygdalina leaf might be used as an 
analgesic and antipyretic remedy.
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